A Spotlight on Psychedelic Research Methods

“Although some challenges are shared with psychotherapy and pharmacology trials more broadly, psychedelic clinical trials have to contend with several unique sources of potential bias”, write Aday et al. (2022). These methodological challenges abound: (how) can we mask participants to their treatment arm, or to the broader and intensifying hype surrounding psychedelic therapies in popular media, for example?

We solicited a variety of perspectives to help us contextualise the methodological challenges that often appear in psychedelic research…

Part of our Year in Review series

Part of our Year in Review series

This content is part of our 2022 Year in Review, which looks back at the past year through commentary and analysis, interviews and guest contributions.

Receive New Sections in Your Inbox

To receive future sections of the Review in your inbox, join our newsletter…

Browse Other Sections of the Review

To explore our Year in Review, visit this webpage.